Therapeutic Strategies for the Treatment of Angelman syndrome Dr Allyson Berent 2020 FAST Science

Allyson Berent (Part 1) | 2022 FAST Summit on Angelman SyndromeПодробнее

2019 FAST Summit on Angelman Syndrome - Genetics and Therapeutic Overview, Allyson Berent, CSO FASTПодробнее

Overview of the Therapeutic Landscape for Angelman SyndromeПодробнее

2018 FAST Science Summit - Angelman OverviewПодробнее

Overview of the FAST research agenda for gene therapy and genetic editing in Angelman syndromeПодробнее

Allyson Berent (Part 2) | 2022 FAST Summit on Angelman SyndromeПодробнее

Therapeutics 101 with Allyson BerentПодробнее

Vue globale sur le syndrome d’Angelman par Allyson BerentПодробнее

Allyson Berent - GeneTxПодробнее

Updates on the Development of an ASO Therapy for Angelman Syndrome Dr Becky Crean 2020 FAST ScienceПодробнее

The Impact Families Can Have on Developing Meaningful Treatments for Angelman SyndromeПодробнее

Agilis BiotherapeuticsПодробнее

Program Update on Hematopoietic Stem Cell Gene Therapy for Angelman Syndrome Dr Joe Anderson 2020Подробнее

Roche Angelman Syndrome Program Update Dr Brenda Vincenzi 2020 FAST Science SummitПодробнее

Gene Therapy for Angelman Syndrome Through RNA InterferenceПодробнее

Dr Allyson Berent UC Davis Mind Institute ConferenceПодробнее

The Use of GTX 102, an ASO as a Potential Therapeutic for Angelman Syndrome Dr Scott Stromatt 2020Подробнее

James M. Wilson | 2022 FAST Summit on Angelman SyndromeПодробнее

Allyson Berent | 2023 FAST Summit on Angelman SyndromeПодробнее